02359 藥明康德
公司資料 - 損益表
無錫藥明康德新藥開發股份有限公司 股票編號: 02359
WUXI APPTEC CO., LTD. 集團網址: http://www.wuxiapptec.com.cn
2023/12 - 末期
人民幣(K¥)
變動 2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
2019/12
人民幣(K¥)
營業額 / 收益40,340,8072.505%39,354,77822,902,38516,535,43112,872,206
銷售成本(23,968,335)-3.541%(24,848,257)(14,636,870)(10,280,387)(7,866,058)
毛利16,372,47212.863%14,506,5218,265,5156,255,0445,006,148
 
投資物業公平值變動及減值------------
其他項目公平值變動及減值(357,899)43.987%(248,564)(31,615)(56,973)(43,165)
出售項目溢利 / (虧損)------------
其他非經營項目------------
分佔聯營公司及共同控制公司業績(67,560)46.009%(46,271)(117,291)(90,752)(20,717)
除稅前溢利 / (虧損)12,929,60221.765%10,618,4776,015,6093,369,3762,336,968
稅項(2,131,731)24.236%(1,715,866)(879,662)(383,126)(425,559)
已終止經營業務溢利 / (虧損)------------
非控股權益(107,718)21.170%(88,898)(38,792)(26,015)(56,858)
其他項目------------
股東應佔溢利 / (虧損)10,690,15321.290%8,813,7135,097,1552,960,2351,854,551
 
淨財務支出 / (收入)(250,889)709.084%(31,009)(63,360)103,67039,809
折舊及攤銷2,511,85131.053%1,916,6651,479,9431,135,974963,351
董事酬金----127,37270,01651,23436,404
 
核數師意見無保留意見--無保留意見無保留意見無保留意見無保留意見
 
市場價值指標
每股盈利 (仙)364.000--301.000175.000106.00067.500
每股派息 (仙)98.336--89.26651.74030.25020.060
派息比率 (%)27.015%--29.656%29.566%28.538%29.718%
每股現金流 ($)----3.4891.5021.3700.924
每股帳面資產淨值 ($)18.567--15.73713.02211.0906.241
 

Copyright © 2024 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.